Search

Displaying results 2231 - 2240 of 9886 in total
  1. Drug

    Hydroxyzine

    go.drugbank.com/drugs/DB00557
    ApprovedInvestigational

    Hydroxyzine is a first-generation histamine H<sub>1</sub>-receptor antagonist of the dephenylmethane and piperazine classes that exhibits sedative, anxiolytic, and antiemetic properties. … [A1257,A187589] It was first developed in 1955,[A189726] and has since remained a relatively common treatment for allergic conditions such as pruritus, urticaria, dermatoses, and histamine-mediated pruritus

    Products: Nu-hydroxyzine, AA PHARMA HYDROXYZINE CAPSULE 10 mg
  2. Drug

    Chenodeoxycholic acid

    go.drugbank.com/drugs/DB06777
    ApprovedInvestigational

    Chenodeoxycholic acid is a bile acid naturally found in the body.

  3. Drug

    Pentetic acid

    go.drugbank.com/drugs/DB14007
    ApprovedInvestigational

    [A32501] It is currently considered, in all the dosage forms, as a member of the list of approved inactive ingredients for drug products by the FDA. … Pentetic acid, also known as diethylenetriaminepentaacetic acid (DTPA), is a synthetic polyamino carboxylic acid with eight coordinate bond forming sites that can sequester metal ions and form highly stable

    Categories: Compounds used in a research, industrial, or household settingSynonyms: DTP-A
  4. Drug

    Evinacumab

    go.drugbank.com/drugs/DB15354
    ApprovedInvestigational

    rationale for the development of a therapy targeted against ANGPTL3. … Evinacumab is a recombinant human IgG4 monoclonal antibody targeted against angiopoietin-like protein 3 (ANGPTL3) and the first drug of its kind.

  5. Drug

    Infliximab

    go.drugbank.com/drugs/DB00065
    ApprovedInvestigational

    Infliximab is a tumor necrosis factor (TNF-alpha or TNF-α) blocker and a chimeric monoclonal IgG1 antibody composed of human constant (75%) and murine variable (25%) regions [A31469]. … Inflectra, a first biosimilar drug product, was approved in 2016. In December 2017, Ixifi, a second biosimilar that was developed by Pfizer, was granted approval by the FDA.

  6. Drug

    Exemestane

    go.drugbank.com/drugs/DB00990
    ApprovedInvestigational

    Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal women. It irreversibly binds to the ...

    Products: EXEMESTAN AL 25 MG, EXEMESTAN 1A PHARMA 25MG
  7. Drug

    Quinidine

    go.drugbank.com/drugs/DB00908
    Approved

    Quinidine is a D-isomer of [quinine] present in the bark of the Cinchona tree and similar plant species. … [A38016] Due to its side effects and increased risk of mortality, the use of quinidine was reduced over the next few decades.

    Categories: Antiarrhythmics, Class Ia, P-glycoprotein substrates with a Narrow Therapeutic Index
  8. Drug

    Clogestone

    go.drugbank.com/drugs/DB19526
    Experimental

    Clogestone is a small molecule drug. Clogestone has a monoisotopic molecular weight of 364.18 Da.

  9. Drug

    Volpristin

    go.drugbank.com/drugs/DB19604
    Experimental

    Volpristin is a small molecule drug. Volpristin has a monoisotopic molecular weight of 527.26 Da.

    Categories: Streptogramin Group A
  10. Drug

    Spirogermanium

    go.drugbank.com/drugs/DB19618
    Experimental

    Spirogermanium is a small molecule drug. Spirogermanium has a monoisotopic molecular weight of 342.21 Da.